Individual.com logo
  For free personalized news click here!
Select a date:

Newsdesks
Top World News
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Top Topics
Privatisation Fears for Kyrgyz Power Plants
Entree - PacMag Business Combination Doubles Copper Resources
SRI LANKAN FARMERS CONNECT TO MARKETS ON MOBILE PHONES
Pratt & Whitney Rocketdyne's Space Shuttle Main Engines Deliver Hardware to Support Science Experiments Onboard the International Space Station
Internet service providers earned $1.7 million from piracy: gov't
Skateboarder's death leaves many questions
Wind turbines beginning to energize Alaska: More Alaskans harness renewable energy
Educator shares space dreams: Woman named to Teachers in Space program gets high-school students excited about science
Even green pioneers who disagree about cap-and-trade legislation believe it could be good for innovation
Mideast markets face selling pressure: expert
Table bottom

Top Topics
Antitrust
Stock Market
Corporate Performance
Alternative Energy
Insurance
Aerospace & Defense
Banking
Top World News
Currencies
Legal
Table bottom

Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
NOVATO, California, Nov 05, 2009 (PR Newswire Europe via COMTEX) --

Proof-of-Concept Data at 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain

Raptor Pharmaceutical Corp. (Nasdaq: RPTP), today announced that data from a clinical trial of NGX426, the Company's orally administered non-opioid, AMPA/kainate antagonist, will be presented at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November 20-21, 2009 in San Francisco.

...

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright , Individual.com, an Office.com Company. No redistribution allowed.